Market Research Logo

Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017

Fore Pharma announced the results of its Non-Small Cell Lung Cancer patients study in a new report ‘Global Non-Small Cell Lung Cancer Epidemiology and Patient Flow Analysis - 2017’. The report provides insights into Non-Small Cell Lung Cancer epidemiology, Non-Small Cell Lung Cancer diagnosed patients, and Non-Small Cell Lung Cancer treatment rate for top seven pharmaceutical markets. The study measures key indicators such as prevalence of Non-Small Cell Lung Cancer derived from epidemiological analysis, percentage of patients diagnosed with Non-Small Cell Lung Cancer, and percentage of patients treated with a therapy.

The study helps executives estimate Non-Small Cell Lung Cancer market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The report provides estimates and forecasts of Non-Small Cell Lung Cancer prevalence, Non-Small Cell Lung Cancer diagnosis rate, and Non-Small Cell Lung Cancer treatment rate for the period 2016 - 2025. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan. The study design is based on interpretation and analysis of data collected from physicians via primary interviews, registries, scientific journals, literatures, government databases and other secondary sources.

Key Features of the Report:

  • Non-Small Cell Lung Cancer Patient Flow
  • Non-Small Cell Lung Cancer Prevalence
  • Non-Small Cell Lung Cancer Diagnosed Patients
  • Non-Small Cell Lung Cancer Treated Patients


1. Non-Small Cell Lung Cancer: Disease Definition
2. Global Non-Small Cell Lung Cancer Patient Flow
2A. Global Non-Small Cell Lung Cancer Prevalence
2B. Global Non-Small Cell Lung Cancer Diagnosed Patients
2C. Global Non-Small Cell Lung Cancer Treated Patients
3. Non-Small Cell Lung Cancer Patient Flow in the US
3A. Non-Small Cell Lung Cancer Prevalence in the US
3B. Non-Small Cell Lung Cancer Diagnosed Patients in the US
3C. Non-Small Cell Lung Cancer Treated Patients in the US
4. Non-Small Cell Lung Cancer Patient Flow in Europe
4A. Non-Small Cell Lung Cancer Prevalence in Europe
4B. Non-Small Cell Lung Cancer Diagnosed Patients in Europe
4C. Non-Small Cell Lung Cancer Treated Patients in Europe
5. Non-Small Cell Lung Cancer Patient Flow in Germany
5A. Non-Small Cell Lung Cancer Prevalence in Germany
5B. Non-Small Cell Lung Cancer Diagnosed Patients in Germany
5C. Non-Small Cell Lung Cancer Treated Patients in Germany
6. Non-Small Cell Lung Cancer Patient Flow in France
6A. Non-Small Cell Lung Cancer Prevalence in France
6B. Non-Small Cell Lung Cancer Diagnosed Patients in France
6C. Non-Small Cell Lung Cancer Treated Patients in France
7. Non-Small Cell Lung Cancer Patient Flow in Spain
7A. Non-Small Cell Lung Cancer Prevalence in Spain
7B. Non-Small Cell Lung Cancer Diagnosed Patients in Spain
7C. Non-Small Cell Lung Cancer Treated Patients in Spain
8. Non-Small Cell Lung Cancer Patient Flow in Italy
8A. Non-Small Cell Lung Cancer Prevalence in Italy
8B. Non-Small Cell Lung Cancer Diagnosed Patients in Italy
8C. Non-Small Cell Lung Cancer Treated Patients in Italy
9. Non-Small Cell Lung Cancer Patient Flow in UK
9A. Non-Small Cell Lung Cancer Prevalence in UK
9B. Non-Small Cell Lung Cancer Diagnosed Patients in UK
9C. Non-Small Cell Lung Cancer Treated Patients in UK
10. Non-Small Cell Lung Cancer Patient Flow in Japan
10A. Non-Small Cell Lung Cancer Prevalence in Japan
10B. Non-Small Cell Lung Cancer Diagnosed Patients in Japan
10C. Non-Small Cell Lung Cancer Treated Patients in Japan
11. Research Methodology
List of Tables
Table 1: Global Non-Small Cell Lung Cancer Patient Flow, 2016
Table 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2016 - 2025
Table 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2016
Table 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2016 - 2025
Table 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
Table 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
Table 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
Table 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
Table 9: Non-Small Cell Lung Cancer Patient Flow in France, 2016
Table 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
Table 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
Table 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
Table 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
Table 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
Table 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
Table 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025
Table 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2016
Table 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2016 - 2025
List of Figures
Figure 1: Global Non-Small Cell Lung Cancer Patient Flow, 2016
Figure 2: Global Non-Small Cell Lung Cancer Patient Flow Forecast, 2016 - 2025
Figure 3: Non-Small Cell Lung Cancer Patient Flow in the US, 2016
Figure 4: Non-Small Cell Lung Cancer Patient Flow Forecast in the US, 2016 - 2025
Figure 5: Non-Small Cell Lung Cancer Patient Flow in Europe, 2016
Figure 6: Non-Small Cell Lung Cancer Patient Flow Forecast in Europe, 2016 - 2025
Figure 7: Non-Small Cell Lung Cancer Patient Flow in Germany, 2016
Figure 8: Non-Small Cell Lung Cancer Patient Flow Forecast in Germany, 2016 - 2025
Figure 9: Non-Small Cell Lung Cancer Patient Flow in France, 2016
Figure 10: Non-Small Cell Lung Cancer Patient Flow Forecast in France, 2016 - 2025
Figure 11: Non-Small Cell Lung Cancer Patient Flow in Spain, 2016
Figure 12: Non-Small Cell Lung Cancer Patient Flow Forecast in Spain, 2016 - 2025
Figure 13: Non-Small Cell Lung Cancer Patient Flow in Italy, 2016
Figure 14: Non-Small Cell Lung Cancer Patient Flow Forecast in Italy, 2016 - 2025
Figure 15: Non-Small Cell Lung Cancer Patient Flow in UK, 2016
Figure 16: Non-Small Cell Lung Cancer Patient Flow Forecast in UK, 2016 - 2025
Figure 17: Non-Small Cell Lung Cancer Patient Flow in Japan, 2016
Figure 18: Non-Small Cell Lung Cancer Patient Flow Forecast in Japan, 2016 - 2025

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report